Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in Severe, Persistent Asthma
NCT00675649Phase 2Withdrawn
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of golimumab in asthma, sponsored by Janssen Pharmaceutical. Planned start May 2008; status: withdrawn.
02
Drugs
golimumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00675649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675649.